Incyte
INCY
#1204
Rank
โ‚น1.836 T
Marketcap
โ‚น9,195
Share price
1.72%
Change (1 day)
75.14%
Change (1 year)

EPS for Incyte (INCY)

EPS in 2025 (TTM): โ‚น578.46

According to Incyte's latest financial reports the company's current EPS (TTM) is โ‚น626.21. In 2024 the company made an earnings per share (EPS) of โ‚น29.41 a decrease over its 2023 EPS that were of โ‚น253.33.

EPS history for Incyte from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น578.461866.69%
2024โ‚น29.41-88.39%
2023โ‚น253.3373.38%
2022โ‚น146.12-64.1%
2021โ‚น407.04-408.63%
2020-โ‚น131.88-166.83%
2019โ‚น197.35300%
2018โ‚น49.34-133.33%
2017-โ‚น148.01-378.57%
2016โ‚น53.132700%
2015โ‚น1.90-106.67%
2014-โ‚น28.46-44.44%
2013-โ‚น51.2450%
2012-โ‚น34.16

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
โ‚น683.14 9.09%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น129.04-79.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,185 248.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น1,360 117.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚น597.74-4.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
-โ‚น12.33-101.97%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
-โ‚น55.03-108.79%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
-โ‚น79.70-112.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-โ‚น23.72-103.79%๐Ÿ‡บ๐Ÿ‡ธ USA